DR LAL PATHLABS
Quarterly Results Analysis [Mar2025]
DR LAL PATHLABS Quarterly Results
Consolidated | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹603 Cr | ₹597 Cr | ₹660 Cr | ₹602 Cr | ₹545 Cr | ₹539 Cr | ₹601 Cr | ₹541 Cr |
Expenses | ₹434 Cr | ₹443 Cr | ₹458 Cr | ₹432 Cr | ₹401 Cr | ₹398 Cr | ₹424 Cr | ₹395 Cr |
Operating Income | ₹169 Cr | ₹154 Cr | ₹203 Cr | ₹170 Cr | ₹145 Cr | ₹141 Cr | ₹178 Cr | ₹146 Cr |
Other Income | ₹26 Cr | ₹25 Cr | ₹22 Cr | ₹21 Cr | ₹18 Cr | ₹18 Cr | ₹18 Cr | ₹14 Cr |
Interest | ₹5 Cr | ₹5 Cr | ₹6 Cr | ₹6 Cr | ₹7 Cr | ₹7 Cr | ₹8 Cr | ₹8 Cr |
Depreciation | ₹36 Cr | ₹36 Cr | ₹35 Cr | ₹35 Cr | ₹37 Cr | ₹36 Cr | ₹36 Cr | ₹35 Cr |
Profit Before Tax | ₹153 Cr | ₹138 Cr | ₹183 Cr | ₹150 Cr | ₹120 Cr | ₹116 Cr | ₹152 Cr | ₹118 Cr |
Profit After Tax | ₹156 Cr | ₹98 Cr | ₹131 Cr | ₹108 Cr | ₹86 Cr | ₹82 Cr | ₹111 Cr | ₹84 Cr |
EPS | ₹18.52 | ₹11.57 | ₹15.45 | ₹12.74 | ₹10.12 | ₹9.74 | ₹13.09 | ₹9.90 |
Industry Peers & Returns | 1W | 1M | 1Y |
DR LAL PATHLABS | 3.6% | 4.3% | -0.5% |
MAX HEALTHCARE INSTITUTE | -2.7% | 4.7% | 35% |
APOLLO HOSPITALS ENTERPRISE | 1.3% | 4.3% | 13.8% |
FORTIS HEALTHCARE | 2% | 6.6% | 66% |
GLOBAL HEALTH | -0.6% | 13.4% | 11.2% |
NARAYANA HRUDAYALAYA | -3.5% | 4.2% | 57.7% |
KRISHNA INSTITUTE OF MEDICAL SCIENCES | 7.3% | 17.4% | 74.4% |
ASTER DM HEALTHCARE | -0.9% | 4% | 77.2% |
RAINBOW CHILDRENS MEDICARE | -0% | 6% | 29.7% |
DR LAL PATHLABS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 0.99 % |
Y-o-Y | 10.49 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹603 Cr | 0.99 | |
Dec2024 | ₹597 Cr | -9.62 | |
Sep2024 | ₹660 Cr | 9.69 | |
Jun2024 | ₹602 Cr | 10.36 | |
Mar2024 | ₹545 Cr | 1.21 | |
Dec2023 | ₹539 Cr | -10.38 | |
Sep2023 | ₹601 Cr | 11.15 | |
Jun2023 | ₹541 Cr | - |
DR LAL PATHLABS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 9.74 % |
Y-o-Y | 16.79 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹169 Cr | 9.74 | |
Dec2024 | ₹154 Cr | -23.95 | |
Sep2024 | ₹203 Cr | 19.12 | |
Jun2024 | ₹170 Cr | 17.48 | |
Mar2024 | ₹145 Cr | 2.92 | |
Dec2023 | ₹141 Cr | -20.92 | |
Sep2023 | ₹178 Cr | 21.61 | |
Jun2023 | ₹146 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 8.68 % |
Y-o-Y | 5.73 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 28.05% | 8.68 | |
Dec2024 | 25.81% | -15.85 | |
Sep2024 | 30.67% | 8.60 | |
Jun2024 | 28.24% | 6.45 | |
Mar2024 | 26.53% | 1.69 | |
Dec2023 | 26.09% | -11.77 | |
Sep2023 | 29.57% | 9.44 | |
Jun2023 | 27.02% | - |
DR LAL PATHLABS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 58.51 % |
Y-o-Y | 81.24 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹156 Cr | 58.51 | |
Dec2024 | ₹98 Cr | -25.00 | |
Sep2024 | ₹131 Cr | 21.34 | |
Jun2024 | ₹108 Cr | 25.64 | |
Mar2024 | ₹86 Cr | 4.38 | |
Dec2023 | ₹82 Cr | -25.75 | |
Sep2023 | ₹111 Cr | 32.42 | |
Jun2023 | ₹84 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 56.93 % |
Y-o-Y | 64.02 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 25.8 % | 56.93 | |
Dec2024 | 16.44 % | -17.01 | |
Sep2024 | 19.81 % | 10.61 | |
Jun2024 | 17.91 % | 13.86 | |
Mar2024 | 15.73 % | 3.15 | |
Dec2023 | 15.25 % | -17.16 | |
Sep2023 | 18.41 % | 19.16 | |
Jun2023 | 15.45 % | - |
DR LAL PATHLABS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 60.07 % |
Y-o-Y | 83.00 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹18.52 | 60.07 | |
Dec2024 | ₹11.57 | -25.11 | |
Sep2024 | ₹15.45 | 21.27 | |
Jun2024 | ₹12.74 | 25.89 | |
Mar2024 | ₹10.12 | 3.90 | |
Dec2023 | ₹9.74 | -25.59 | |
Sep2023 | ₹13.09 | 32.22 | |
Jun2023 | ₹9.9 | - |
You may also like the below Video Courses